Navigation Links
Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
Date:11/22/2013

ical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the absence of guarantee that the product candidates if approved will be commercially successful, the future approval and commercial success of therapeutic alternatives, the Group's ability to benefit from external growth opportunities, trends in exchange rates and prevailing interest rates, the impact of cost containment policies and subsequent changes thereto, the average number of shares outstanding as well as those discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in Sanofi's annual report on Form 20-F for the year ended December 31, 2012.  Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

Regeneron Forward-Looking StatementsThis news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron, and actual events or results may differ materially from these forward-looking statements.  Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words.  These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of Regene
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... plc (NYSE: MNK ) announced today that ... program. The open-ended authorization permits the company to repurchase ... "Funding additional initiatives and seeking attractive ... to pursue a range of focused growth strategies," said ...
(Date:1/23/2015)... , Jan. 23, 2015 Tianyin Pharmaceutical Inc. ... that specializes in the development and sale of patented ... and active pharmaceutical ingredients (API) today announced the business ... API operation. 1. Following the September 2014 ...
(Date:1/22/2015)... Jan. 22, 2015  Uroplasty, Inc. (NASDAQ: UPI ), ... innovative proprietary products to treat voiding dysfunctions, today reported ... 31, 2014.  Global revenue for the Company,s ... million, a new quarterly revenue record, as compared to ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
... a leading Clinical Research Organization, announces the expansion of operations ... accommodate staff growth and strong client demand for our Phase ... city of Utrecht, NL, this new Dutch facility will host ... region to primarily support Product Registration trials. Staff from our ...
... Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of ... present at the 11th National Life Science & Technology Week ... The presentation will be given by Nadav Kidron, Oramed,s President ... during the BioPharma Session. Event: ...
Cached Medicine Technology:PRA Expands Operations in Europe 2Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012 2
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... released a new blog post explaining the main features of ... Auto insurance quotes help many drivers find the best coverage ... an agent or visit an agency for price information. These ... http://autocarinsurancebest.com/ . , Every business who relies heavily on transportation ...
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
Breaking Medicine News(10 mins):Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... parent to be there for their,child,s first breath and last ... those two breaths.," -- Keith Moore, "Moore,s journey ... rely on,your faith during troubled times..." -- Chip Foose, ... Sept. 18 Old at Age 3: The Story,of Zachary ...
... immune response, scientists say , TUESDAY, Sept. 18 (HealthDay ... appears to be associated with rheumatoid arthritis, European researchers ... and elsewhere, conducted genetic analyses of hundreds of rheumatoid ... the disease and one region of the genome. This ...
... VIEW, Calif., Sept. 18 Pharsight,Corporation (OTC Bulletin ... services for optimizing clinical drug development, today,announced that ... common stock on the,Nasdaq Capital Market. The Company ... "This application is an important milestone for ...
... Give Free Fondue for a Year, TAMPA, Fla., Sept. ... woman who awoke from a two-week coma with a craving ... free fondue,for a year. The Melting Pot will fly Jill ... to receive the gift at its annual,meeting. On May ...
... Wellcorps,International, the leading formulator and distributor ... and products, has introduced two,new nutritional supplements, ... male nutrient support system supplement. Perspective(TM) ... vast array of specialty botanicals and,proprietary blends ...
... YORK, Sept. 17 HealthShares(TM) Inc., an investment,company with ... been,informed that Standard & Poor,s, the official calculating agent ... the,Indexes. The following securities will be added and ... on the New York Stock Exchange,September 21, 2007.,Autoimmune-Inflammation,Drop Nektar ...
Cached Medicine News:Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 2Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 3Health News:Old at Age 3: The Inspiring Life of Progeria Patient Zachary Moore 4Health News:Pharsight Files Application for Nasdaq Capital Market Listing 2Health News:Pharsight Files Application for Nasdaq Capital Market Listing 3Health News:Update on Jill Finley Story, Coma Survivor 2Health News:Wellcorps International Unveils New Nutritional Supplements 2Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 16Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 17Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 18Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 19Health News:HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes 20
Welch Allyn quality in a convenient pocket size. The PocketScope fits into your pocket! Easy to use, lightweight, and perfect for general and specialist use. Take your PocketScope with you everywhere...
... enables a fast, precise patternless edge for ... the TOPCON ALE-X1. The latest advance in ... improved features and functions. High-speed processing, a ... beveled edges, precise three-dimensional frame tracing via ...
... versatile 32-bit color mapping software system enhances ... accurate, full color corneal maps. The system ... maps, sagittal maps, refractive and keratometric data, ... phase detection of subclinical keratoconus as well ...
... computer-integrated, flexibility, combined with the ultimate ... styling, make the new Topcon Express ... competitive 21st Century practice environments: Ultimate ... fits comfortably in an 8' X ...
Medicine Products: